Introduction

Despite 5 of the 7 constituents in the American Cannabis MSOs Portfolio releasing their Q1 financial reports earlier this week the portfolio went down 5.0% and is now down 18.9% from its high reached on April 30th. Below is how each constituent fared this week, in descending order, since their peak prices on April 30th, and YTD along with their reported Q1  profit or loss as a percentage of quarterly revenue for comparison purposes and links to my articles on said quarterly reports:

1. Green Thumb (GTBIF): down 2.1% w/e May 10th; down 16.0% since April 30th; up 14.4% YTD
   • Q1 profit as a % of Revenue: 11.3%
   • Green Thumb Q1 Financial Metrics Excel Across The Board
2. Curaleaf (CURLF): down 2.7% w/e May 10th; down 12.4% since April 30th; up 32.5% YTD
   • Q1 loss as a % of Revenue: (142.5)%
   • Curaleaf Reports 16% Reduction In Net Loss In Q1 Financial Report
3. Verano (VRNOF): down 3.1% w/e May 10th; down 20.9% since April 30th; up 12.2% YTD
   • Q1 loss as a % of Revenue: (2.2)%
   • Verano Q1 Financial Metrics Down Across The Board
4. Cresco Labs (CRLBF): down 5.5% w/e May 10th; down 20.8% since April 30th; up 51.9% YTD
   • Q1 report to be released on May 15th
5. TerrAscend (TSNDF): down 6.3% w/e May 10th; down 24.3% since April 30th; up 1.2% YTD
   • Q1 loss as a % of Revenue: (184.9)%
   • TerrAscend Reports 64% Reduction In Net Loss In Q1 Financial Report
6. Trulieve Cannabis (TCNNF): down 8.0% w/e May 10th; down 19.6% since April 30th; up 121.3% YTD
   • Q1 loss as a % of Revenue: (7.7)%
   • Trulieve Cannabis Q1 Financial Results Impressive
7. Ayr Wellness (AYRWF): down 13.2% w/e May 10th; down 32.3% since April 30th; up 28.3% YTD
   • Q1 report to be released on May 15th

Average: down 5.0% w/e May 10th; down 18.9% since April 30th; up 37.1% YTD

More By This Author:

5 Of 7 AI Categories Rose, Slightly, Over Past Week
TerrAscend Reports 64% Reduction In Net Loss In Q1 Financial Report
Curaleaf Reports 16% Reduction In Net Loss In Q1 Financial Report